Adverse events
| Control (n=53) | Fish oil (n=86) | |
|---|---|---|
| Participants with an AE or SAE Number of AEs+SAEs per person (median (IQR)) | 49 (92.4%) 3 (2.4) | 74 (86.0%) 2 (1.4) |
| Participants with an SAE | 2 (3.8%) | 10 (11.6%) |
| Total no of SAEs (all were hospital admissions) | 3 | 20 |
| Organ systems of SAEs | ||
| Cardiac | ||
| Myocardial infarction | 2 | |
| Myocardial ischemia | 2 | |
| Arrhythmia | 2 | |
| Gastrointestinal | ||
| Acute gastric ulcer | 1 | |
| Cholelithiasis | 1 | |
| Infection | ||
| Suspected H. Zoster infection | 1 | |
| Infectious mononucleosis | 1 | |
| Injury | ||
| Superficial neck injury | 1 | |
| Malignancy | ||
| Amyloidosis | 2* | |
| Metabolic | ||
| Hyperglycaemia | 1 | |
| Hyponatremia | 1 | |
| Nervous system | ||
| TIA | 1 | |
| Intracerebral bleed | 1 | |
| Respiratory | ||
| Hypersensitivity pneumonitis | 1 | |
| COPD exacerbation | 1 | |
| Surgical or medical procedure | 4† |
*Two hospital admissions for same subject.
†Atrial flutter ablation, cholecystectomy, nephrolithotomy, carotid endarterectomy.
SAE, serious adverse event.